Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt
- PMID: 12740346
- PMCID: PMC1773665
- DOI: 10.1136/gut.52.6.879
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt
Abstract
Background: In patients undergoing transjugular intrahepatic portosystemic shunt (TIPS), prognostic scores may identify those with a poor prognosis or even those with a clear survival benefit. The Child-Pugh score (CPS) is well established but several drawbacks have led to development of the model of end stage liver disease (MELD).
Aim: The aim of the study was to compare the predictive power of CPS and MELD, to validate the original MELD formula, and to assess the predictive value of the determinants used in the two prognostic scores outside of a study setting.
Patients: A total of 501 patients underwent elective TIPS placement and 475 patients fulfilled the inclusion criteria.
Methods: Data of all patients undergoing elective TIPS in one university hospital and four community hospitals in Vienna, Austria, between 1991 and 2001, were analysed retrospectively. The main statistical tests were Cox proportional hazards regression model, the log rank test, Kaplan-Meier analysis, and concordance c statistics.
Results: Median follow up was 5.2 years and median survival was 4.6 years. During follow up, 230 patients died, 75 within three months after TIPS placement. In stepwise proportional hazards analyses, independent predictors of death were creatinine level, bilirubin level, age, and refractory ascites. MELD was better in predicting survival in a stepwise Cox model but both scores were equally predictive in c statistics for one month, three month, and one year survival. Renal function was the strongest independent predictor of survival.
Conclusions: Although MELD was the primary predictor of overall survival in multivariate analysis, c statistics showed that both scores can be used for patients undergoing TIPS with equal accuracy. For assessing prognosis in patients undergoing TIPS implantation, there seems little reason to replace the well established Child-Pugh score.
Figures




Similar articles
-
MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.J Hepatol. 2002 Apr;36(4):494-500. doi: 10.1016/s0168-8278(01)00309-9. J Hepatol. 2002. PMID: 11943420
-
Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.Korean J Radiol. 2009 Sep-Oct;10(5):481-9. doi: 10.3348/kjr.2009.10.5.481. Epub 2009 Aug 25. Korean J Radiol. 2009. PMID: 19721833 Free PMC article.
-
Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.World J Gastrointest Surg. 2024 Feb 27;16(2):481-490. doi: 10.4240/wjgs.v16.i2.481. World J Gastrointest Surg. 2024. PMID: 38463353 Free PMC article.
-
Predictive Accuracy Comparison of Prognostic Scoring Systems for Survival in Patients Undergoing TIPS Placement: A Systematic Review and Meta-analysis.Acad Radiol. 2024 Sep;31(9):3688-3710. doi: 10.1016/j.acra.2023.10.050. Epub 2023 Nov 23. Acad Radiol. 2024. PMID: 38000922
-
Model for End-stage Liver Disease.J Clin Exp Hepatol. 2013 Mar;3(1):50-60. doi: 10.1016/j.jceh.2012.11.002. Epub 2012 Dec 1. J Clin Exp Hepatol. 2013. PMID: 25755471 Free PMC article. Review.
Cited by
-
Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia.Saudi Med J. 2024 Jul;45(7):675-684. doi: 10.15537/smj.2024.45.7.20240156. Saudi Med J. 2024. PMID: 38955454 Free PMC article.
-
Treatment for Hepatocellular Carcinoma in South Asia.J Clin Exp Hepatol. 2021 Nov-Dec;11(6):641-645. doi: 10.1016/j.jceh.2021.09.018. Epub 2021 Sep 24. J Clin Exp Hepatol. 2021. PMID: 34866841 Free PMC article. No abstract available.
-
Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.J Gastroenterol. 2008;43(5):363-8. doi: 10.1007/s00535-008-2168-7. Epub 2008 Jul 1. J Gastroenterol. 2008. PMID: 18592154
-
Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy.Semin Intervent Radiol. 2005 Dec;22(4):309-15. doi: 10.1055/s-2005-925557. Semin Intervent Radiol. 2005. PMID: 21326709 Free PMC article.
-
Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis.World J Hepatol. 2016 Jun 18;8(17):739-48. doi: 10.4254/wjh.v8.i17.739. World J Hepatol. 2016. PMID: 27330683 Free PMC article.
References
-
- Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165–71. - PubMed
-
- Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701–7. - PubMed
-
- Sanyal AJ. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep 2000;2:61–71. - PubMed
-
- Ochs A, Rössle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites (published erratum appears in N Engl J Med 1995;332:1587). N Engl J Med 1995;332:1192–7. - PubMed
-
- Rössle M, Deibert P, Haag K, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;349:1043–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical